TFX Teleflex Incorporated

Teleflex Announces 2020 Annual Meeting of Stockholders to be Held in Virtual-Only Format

Teleflex Announces 2020 Annual Meeting of Stockholders to be Held in Virtual-Only Format

WAYNE, Pa., April 17, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that its 2020 annual meeting of stockholders (the “Annual Meeting”) will be conducted exclusively online by remote communication due to public health concerns regarding COVID-19 and government-recommended and required limits on gatherings and events, and to support the health and well-being of our stockholders, employees, directors and other participants.

The meeting will be held at the previously announced date and time of May 1, 2020 at 11:00 a.m., Eastern Time. Stockholders will not be able to attend the Annual Meeting in person, however stockholders attending the Annual Meeting virtually can vote their shares during the Annual Meeting by following the instructions below.

The proxy card previously distributed will not be updated to reflect the virtual-only meeting format and may continue to be used to vote your shares in connection with the Annual Meeting. Whether or not stockholders plan to attend the Annual Meeting, the Company encourages stockholders to vote on the proposals prior to the Annual Meeting using the instructions provided in the proxy materials previously distributed.

Attending the Annual Meeting

Stockholders at the close of business on the record date (March 2, 2020) are entitled to participate in the Annual Meeting, including to vote their shares and ask questions. The meeting can be accessed via the internet at /TFX2020. To be admitted to the virtual meeting, stockholders must enter the control number found on their proxy card or instructions accompanying their proxy materials. Stockholders who hold Teleflex shares through a brokerage, bank or other institutional account with questions on how to obtain a control number to participate in the Annual Meeting should contact the financial institution where their shares are held. Attendance at the virtual Annual Meeting will be limited to our stockholders, and guests will not be able to attend the meeting.

Online access to the live audio webcast will open at 10:45 a.m., Eastern Time, on May 1, 2020, to allow time for stockholders to log in and test their device's audio system. We encourage stockholders to access the meeting in advance of the start time.

Questions and Information Accessibility

Stockholders as of the record date who attend and participate in the Annual Meeting using their control number (as described above) will have an opportunity to submit questions during the meeting that are pertinent to the matters to be voted on at the Annual Meeting. Instructions for submitting questions during the meeting will be provided on the Annual Meeting website. A list of stockholders of record as of the record date will be available during the Annual Meeting for inspection by shareholders for any purpose germane to the Annual Meeting. In addition, the list of stockholders of record as of the record date will be made available, through electronic means, for inspection by stockholders for any purpose germane to the Annual Meeting during the ten days preceding the Annual Meeting. To access the electronic stockholder list during this time, stockholders should submit their request, and proof of ownership, through the Investors page of our website,

Technical Support

Any stockholder who encounters difficulties in accessing the Annual Meeting during the log in or meeting time should call the support team at the numbers provided on the Annual Meeting website.

ABOUT TELEFLEX INCORPORATED

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation - a relentless pursuit of identifying unmet clinical needs - to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit .

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift®, and Weck® - trusted brands united by a common sense of purpose.

Contact:

Jake Elguicze

Treasurer and Vice President of Investor Relations

610-948-2836

EN
17/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teleflex Incorporated

 PRESS RELEASE

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved ...

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents WAYNE, Pa., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the enrollment of the first patient in the DUBSTENT DIABETES trial. The randomized, investigator-initiated clinical study will evaluate a dual-device strategy for percutaneous coronary intervention (PCI) in patients with diabetes mellitus. The ...

 PRESS RELEASE

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcar...

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. (ET). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at . About Teleflex IncorporatedAs a global provider of medical technologies, Teleflex is driven by our purpose to improve the ...

 PRESS RELEASE

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a...

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4Initial cases have now been performed in Japan. WAYNE, Pa., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced Barrigel™ rectal spacer is now available for pur...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 9, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Teleflex Inc: 5 directors

Five Directors at Teleflex Inc bought 5,500 shares at between 114.750USD and 115.860USD. The significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch